HER2-low Breast Cancer trials recruiting in Florida

Fewer than 3 recruiting trials found.

All HER2-low Breast Cancer trials nationally

Cities in Florida

Recruiting trials in Florida

• A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
  NCT07383506 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa